Speakers:
Lisa Kottschade, MSN, APRN, CNP – Mayo Clinic
Brianna Hoffner, MSN, ANP-BC, AOCNP®
Kevin Brigle, PhD, ANP – Virginia Commonwealth University, Massey Cancer Center
Josh Epworth, ARNP – University of Washington Medical Center
Kirollos S. Hanna, PharmD, BCPS, BCOP – M Health Fairview and Mayo Clinic College of Medicine
Learning Objectives:
- Describe current approaches to cancer immunotherapy including checkpoint inhibition, bispecific antibodies, CAR-T, TIL and combination therapies
- Identify the role of immunotherapy in the adjuvant setting and unique considerations regarding toxicities and therapeutic options in the event of recurrence
- Discuss recent immunotherapy approvals including the clinical trial endpoints that led to approval
- Review best practices for identification and management of immune-related adverse events
Updates in Immunotherapy: Part 2
Saturday, May 14, 2022
4:45 PM – 6:15 PM CDT
Speakers:
Lisa Kottschade, MSN, APRN, CNP – Mayo Clinic
Brianna Hoffner, MSN, ANP-BC, AOCNP®
Kevin Brigle, PhD, ANP – Virginia Commonwealth University, Massey Cancer Center
Josh Epworth, ARNP – University of Washington Medical Center
Eve Segal, PharmD, BCOP – Seattle Cancer Care Alliance/University of Washington Medical Center
Learning Objectives:
- Identify factors that may affect IO treatment response
- Describe important drug-drug interactions the AP should monitor for in patients receiving IO
- Understand the role of PDL1 and MSI status in guiding treatment decisions
- Discuss complex treatment decisions in patients with comorbid conditions such as autoimmune disorders, history of transplant or multiple malignancies
For more information, and to register, go to
https://thejadproworkshop.com/